Skip to Content
 

News: Breast Cancer Research Program

Clues to bone metastases

Monday, November 5th, 2018

A recent study by Rachelle Johnson, Ph.D., and colleagues looked at factors influencing the ability of breast cancer cells to colonize bone and enter and exit a dormant state.

Cancer Center investigators awarded Komen grants

Friday, October 12th, 2018

Vanderbilt-Ingram Cancer Center (VICC) investigators have received financial support from Susan G. Komen for breast cancer research.

Team identifies new gene candidates for breast cancer risk

Monday, July 2nd, 2018

A new study has identified 48 candidate susceptibility genes for breast cancer risk, including 14 genes at loci (chromosome regions) not yet reported for breast cancer.

Park named to VICC breast cancer leadership position

Thursday, May 17th, 2018

Ben Ho Park, MD, PhD, has been named co-leader of the Breast Cancer Research Program, director of Precision Oncology and associate director for Translational Research at Vanderbilt-Ingram Cancer Center. He will assume his new post Sept. 1.

VICC breast cancer leaders named Komen Scholars

Friday, April 13th, 2018

Ingrid Mayer, MD, MSCI, Ingram Professor of Cancer Research and leader of the Breast Cancer Research Program, has been named a Komen Scholar for her leadership in breast cancer research. She is joined by Wayne Dornan, PhD, a patient research advocate at VICC, who will serve on the Advocates in Science Steering Committee for Susan G. Komen.

Study seeks to boost breast tumor immune response

Thursday, February 8th, 2018

Targeting specific molecules in breast tumors, called methylating agents, can turn up the immune response, potentially making tumors responsive to immunotherapy, suggests a new study published in Nature Communications.

Macara named ‘Pink Tie Guy’ for Komen breast cancer research

Thursday, January 11th, 2018

Ian Macara, PhD, Louise B. McGavock Professor and Chair of Cell and Developmental Biology and co-leader of the Signal Transduction and Chemical Biology Research Program at Vanderbilt-Ingram Cancer Center (VICC), has been named one of the Pink Tie Guys for the Susan G. Komen Central Tennessee organization.

Study to test combination therapy for breast cancer

Friday, October 27th, 2017

Vanderbilt-Ingram Cancer Center has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer.

VICC investigators land support from Komen Foundation

Tuesday, October 3rd, 2017

Three breast cancer investigators from Vanderbilt-Ingram Cancer Center (VICC) have been awarded research grants from Susan G. Komen, a nonprofit foundation devoted to supporting cancer research, community health outreach, advocacy and public policy initiatives.

Stress may switch on bone “mets”

Friday, August 11th, 2017

Stress stimulates the formation of blood vessels in bone and may help breast cancer cells to invade this organ. In the July issue of the Journal of Bone and Mineral Research, Florent Elefteriou, Ph.D., Julie A. Sterling, Ph.D., and colleagues describe a mechanism for skeletal colonization by breast cancer cells that could lead to new ways to […]

Next Page »